Sirolimus: A Successful Medical Treatment for Head and Neck Lymphatic Malformations

Joint Authors

Curry, Steven
Logeman, Andrew
Jones, Dwight

Source

Case Reports in Otolaryngology

Issue

Vol. 2019, Issue 2019 (31 Dec. 2019), pp.1-3, 3 p.

Publisher

Hindawi Publishing Corporation

Publication Date

2019-03-24

Country of Publication

Egypt

No. of Pages

3

Main Subjects

Diseases

Abstract EN

Lymphatic malformations are abnormalities that arise in the developing lymphatic system, most frequently presenting in the head and neck.

They are typically treated with sclerotherapy, laser therapy, or surgery for localized lesions.

Sirolimus, an inhibitor of the mammalian target of rapamycin, is a relatively new medical therapy for the treatment of vascular malformations.

This case report presents the improvements and complications seen in a female infant who was diagnosed with a large lymphatic malformation on prenatal ultrasound and has been treated with sirolimus during the first 9 months of life.

American Psychological Association (APA)

Curry, Steven& Logeman, Andrew& Jones, Dwight. 2019. Sirolimus: A Successful Medical Treatment for Head and Neck Lymphatic Malformations. Case Reports in Otolaryngology،Vol. 2019, no. 2019, pp.1-3.
https://search.emarefa.net/detail/BIM-1143180

Modern Language Association (MLA)

Curry, Steven…[et al.]. Sirolimus: A Successful Medical Treatment for Head and Neck Lymphatic Malformations. Case Reports in Otolaryngology No. 2019 (2019), pp.1-3.
https://search.emarefa.net/detail/BIM-1143180

American Medical Association (AMA)

Curry, Steven& Logeman, Andrew& Jones, Dwight. Sirolimus: A Successful Medical Treatment for Head and Neck Lymphatic Malformations. Case Reports in Otolaryngology. 2019. Vol. 2019, no. 2019, pp.1-3.
https://search.emarefa.net/detail/BIM-1143180

Data Type

Journal Articles

Language

English

Notes

Includes bibliographical references

Record ID

BIM-1143180